GGrantIndex
← Leaderboards

Richard D Minshall

University Of Illinois At Chicago

$14,002,730
Attributed
$19,579,450
Total exposure
11
Grants
8
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.7M · FY200525
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$19,579,450 · 11

By mechanism

R01$12,794,576 · 4
P01$5,651,162 · 4
P30$581,408 · 1
R56$327,795 · 1
S10$224,509 · 1

Top collaborators

Most similar at University Of Illinois At Chicago

Same institution · by research overlap

Others in their field

Top investigators on “Blood Vessels

Research focus

Blood VesselsSignal TransductionMediatingEndothelial CellsPathway InteractionsBasePermeabilityLungRegulationEventPhosphorylationSignal PathwayInflammatoryAlbuminsImageUptakeCaveolin 1In VivoPhysiologicalAdhesionsInsightLeadMembraneModification

Grant awards (53)

CACHET - Environmental Biomarkers Core$301,417
P30 · FY2025 · ES · contact PI
CACHET - Environmental Biomarkers Core$279,991
P30 · FY2024 · ES · contact PI
Fibroblast Mediated Mechanisms of Pulmonary Hypertension$399,750
R01 · FY2023 · HL · contact PI
Endothelial biomechanics in vascular aging$327,795
R56 · FY2023 · AG
Fibroblast Mediated Mechanisms of Pulmonary Hypertension$399,750
R01 · FY2022 · HL · contact PI
Impact of dyslipidemia on endothelial biomechanics$568,540
R01 · FY2021 · HL
Fibroblast Mediated Mechanisms of Pulmonary Hypertension$399,750
R01 · FY2021 · HL · contact PI
Impact of dyslipidemia on endothelial biomechanics$574,005
R01 · FY2020 · HL
Fibroblast Mediated Mechanisms of Pulmonary Hypertension$399,750
R01 · FY2020 · HL · contact PI
Impact of dyslipidemia on endothelial biomechanics$579,314
R01 · FY2019 · HL
Fibroblast Mediated Mechanisms of Pulmonary Hypertension$399,750
R01 · FY2019 · HL · contact PI
New strategies for treating septic vasculopathy, inflammation and thrombosis$713,873
R01 · FY2018 · HL
Impact of dyslipidemia on endothelial biomechanics$584,467
R01 · FY2018 · HL
New strategies for treating septic vasculopathy, inflammation and thrombosis$713,873
R01 · FY2017 · HL
New strategies for treating septic vasculopathy, inflammation and thrombosis$647,554
R01 · FY2016 · HL
Impact of dyslipidemia on endothelial biomechanics$548,858
R01 · FY2016 · HL
New Strategies for Treating Septic Vasculopathy Inflammation and Thrombosis$61,326
R01 · FY2016 · HL
New strategies for treating septic vasculopathy, inflammation and thrombosis$637,840
R01 · FY2015 · HL
Impact of dyslipidemia on endothelial biomechanics$540,625
R01 · FY2015 · HL
Src Regulation of Lung Endothelial Barrier Function$330,765
P01 · FY2015 · HL · contact PI
Imaging and Physiology Core$231,264
P01 · FY2015 · HL · contact PI
New strategies for treating septic vasculopathy, inflammation and thrombosis$647,554
R01 · FY2014 · HL
Impact of dyslipidemia on endothelial biomechanics$537,881
R01 · FY2014 · HL
Src Regulation of Lung Endothelial Barrier Function$328,303
P01 · FY2014 · HL · contact PI
Imaging and Physiology Core$230,789
P01 · FY2014 · HL · contact PI
Impact of dyslipidemia on endothelial biomechanics$522,513
R01 · FY2013 · HL
Src Regulation of Lung Endothelial Barrier Function$319,514
P01 · FY2013 · HL · contact PI
Imaging and Physiology Core$224,608
P01 · FY2013 · HL · contact PI
Impact of dyslipidemia on endothelial biomechanics$548,858
R01 · FY2012 · HL
Src Regulation of Lung Endothelial Barrier Function$335,112
P01 · FY2012 · HL · contact PI
Imaging and Physiology Core$235,577
P01 · FY2012 · HL · contact PI
Caveolin-1 and NO Regulate PMN-mediated Increases in Vascular Permeability$387,500
R01 · FY2011 · HL · contact PI
Src Regulation of Lung Endothelial Barrier Function$334,730
P01 · FY2011 · HL · contact PI
Imaging and Physiology Core$235,309
P01 · FY2011 · HL · contact PI
Caveolin-1 and NO Regulate PMN-mediated Increases in Vascular Permeability$387,500
R01 · FY2010 · HL · contact PI
Caveolin-1 and NO Regulate PMN-mediated Increases in Vascular Permeability$387,500
R01 · FY2009 · HL · contact PI
Src Regulation of Lung Endothelial Barrier Function$313,539
P01 · FY2009 · HL · contact PI
CORE--Imaging and Physiology Core$290,731
P01 · FY2009 · HL · contact PI
Caveolin-1 and NO Regulate PMN-mediated Increases in Vascular Permeability$18,212
R01 · FY2009 · HL · contact PI
Caveolin-1 and NO Regulate PMN-mediated Increases in Vascular Permeability$387,500
R01 · FY2008 · HL · contact PI
Src Regulation of Lung Endothelial Barrier Function$298,401
P01 · FY2008 · HL · contact PI
CORE--Imaging and Physiology Core$271,580
P01 · FY2008 · HL · contact PI
Src Regulation of Lung Endothelial Barrier Function$295,672
P01 · FY2007 · HL · contact PI
CORE--Imaging and Physiology Core$269,943
P01 · FY2007 · HL · contact PI
Zeiss Dynamic Laser TIRF$224,509
S10 · FY2007 · RR · contact PI
Src Regulation of Lung Endothelial Barrier Function$292,538
P01 · FY2006 · HL · contact PI
CORE--Imaging and Physiology Core$267,767
P01 · FY2006 · HL · contact PI
Src Regulation of Lung Endothelial Barrier Function$91,324
R01 · FY2006 · HL · contact PI
Src Regulation of Lung Endothelial Barrier Function$284,019
P01 · FY2005 · HL
CORE--Imaging and Physiology Core$261,001
P01 · FY2005 · HL
Src Regulation of Lung Endothelial Barrier Function$93,522
R01 · FY2005 · HL
Src Regulation of Lung Endothelial Barrier Function$303,947
R01 · FY2004 · HL
Src Regulation of Lung Endothelial Barrier Function$311,740
R01 · FY2003 · HL